Results 181 to 190 of about 39,918 (251)

Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study

Martyna Sikorska, Jakub Chmiel, Elżbieta Papuga-Szela, Elżbieta Broniatowska, Anetta Undas   +4 more
openalex   +1 more source

Risk of long-term anticoagulation under sustained severe arterial hypertension: A translational study comparing warfarin and the new oral anticoagulant apixaban [PDF]

, 2016
Waltraud Pfeilschifter, Thurid Steinstraesser, Patrick Paulus, Pia S. Zeiner, Ferdinand O. Bohmann, A. Theisen, Edelgard Lindhoff‐Last, Cornelia Penski, Marlies Wagner, Michel Mittelbronn, Christian Foerch   +10 more
openalex   +1 more source

Leukocytoclastic Vasculitis Associated with Coumarin Derivatives: A Case Report. [PDF]

Hosp Pharm
Mahadevappa M, Jayaprakash Narayan H, Srinivasan BR, Ravishankar N.   +3 more
europepmc   +1 more source

Аnti-Xa activity in patients with non-valvular atrial fibrillation treated with apixaban and rivaroxaban [PDF]

Evgenia Kochetkova, Drozdov Vn, Е. В. Ших   +2 more
openalex   +1 more source

Solubility enhancement of BCS classified IV drug - Apixaban by preparation and evaluation of Mesoporous Nanomatrix

, 2020
A Patel Amit, Salunkhe Kishor S, Chavan Machindra J, Chintamani Ravindra B, Rajput Singh Rudra Pratap   +4 more
openalex   +2 more sources

Safety And Efficacy Of Uninterrupted Periprocedural Apixaban In Patients Undergoing Atrial Fibrillation Catheter Ablation: A Metaanalysis Of 1,057 Patients.

, 2016
Jalaj Garg, Rahul Chaudhary, Parasuram Krishnamoorthy, Neeraj Shah, Babak Bozorgnia, Andrea Natale   +5 more
openalex   +2 more sources

Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients [PDF]

, 2016

core   +1 more source

Impact of direct oral anticoagulants on blood-brain barrier integrity. [PDF]

IBRO Neurosci Rep
Sato K, Morofuji Y, Shinya D, Nakagawa S, Matsuo T.   +4 more
europepmc   +1 more source

Evaluating the impact of a structured medication optimisation review on prescribing patterns and bleeding risk among patients prescribed direct oral anticoagulants (DOACs): a difference-in-differences study. [PDF]

BMJ Open Qual
Camacho EM, Butters O, Daras K, Downing J, Bateman J, Lynch S, Buchan IE, Barr B.   +7 more
europepmc   +1 more source

Full-dose versus reduced-dose comparison of direct oral anticoagulants for extended treatment of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Zhang R, Wang R, Li Y, Tian W, Niu D, Cheng W, Niu X.   +6 more
europepmc   +1 more source